Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience

By Cristofanilli M.   Holmes F.A.   Esparza L.   Valero V.   Buzdar A.U.   Neidhart J.A.   Hortobagyi G.N.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 3, 1999-04 ,pp. : 225-233

Springer Publishing Company

Access to resources Recommend Favorite

Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised Phase III trial on dose response (EORTC trial 22844)

By Kiebert G.M.   Curran D.   Aaronson N.K.   Bolla M.   Menten J.   Rutten E.H.J.M.   Nordman E.   Silvestre M.E.   Pierart M.   Karim A.B.M.F.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1902-1909

Elsevier

Access to resources Recommend Favorite

The University of Texas M.D. Anderson Cancer Center Code of Ethics-Revised

By van Eys Jan  

Cancer Prevention International, Vol. 3, Iss. 2, 1998-04 ,pp. : 131-140

Cognizant Communication Corporation

Access to resources Recommend Favorite

Three-dimensional conformal radiation therapy for non-small-cell lung cancer: A Phase I/II dose escalation clinical trial

By Wu K.-L.   Jiang G.-L.   Liao Y.   Qian H.   Wang L.-J.   Fu X.-L.   Zhao S.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 5, 2003-12 ,pp. : 1336-1344

Elsevier

Access to resources Recommend Favorite

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

By Bolla M.   Collette L.   Blank L.   Warde P.   Dubois J.B.   Mirimanoff R.-O.   Storme G.   Bernier J.   Kuten A.   Sternberg C.   Mattelaer J.   Lopez Torecilla J.   Pfeffer J.R.   Lino Cutajar C.   Zurlo A.   Pierart M.   Ritter M.A.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 309-310

Elsevier

Access to resources Recommend Favorite